Transcriptome Profile During Rabies Virus Infection: Identification of Human CXCL16 as a Potential New Viral Target.


Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2021
Historique:
received: 19 08 2021
accepted: 23 09 2021
entrez: 22 11 2021
pubmed: 23 11 2021
medline: 26 11 2021
Statut: epublish

Résumé

Rabies virus (RABV), the causative agent for rabies disease is still presenting a major public health concern causing approximately 60,000 deaths annually. This neurotropic virus (genus

Identifiants

pubmed: 34804996
doi: 10.3389/fcimb.2021.761074
pmc: PMC8602097
doi:

Substances chimiques

CXCL16 protein, human 0
Chemokine CXCL16 0
Cxcl16 protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

761074

Informations de copyright

Copyright © 2021 Feige, Sáenz-de-Santa-María, Regnault, Lavenir, Lepelletier, Halacu, Rajerison, Diop, Nareth, Reynes, Buchy, Bourhy and Dacheux.

Déclaration de conflit d'intérêts

Author PB is employed by GSK Vaccines. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Gen Virol. 2014 Apr;95(Pt 4):862-867
pubmed: 24413421
Front Microbiol. 2016 May 19;7:751
pubmed: 27242764
Sci Rep. 2016 Oct 10;6:34633
pubmed: 27721466
J Vet Med Sci. 2016 Aug 1;78(7):1089-98
pubmed: 27041139
Nat Rev Dis Primers. 2017 Nov 30;3:17091
pubmed: 29188797
PLoS Negl Trop Dis. 2015 Apr 16;9(4):e0003709
pubmed: 25881058
PLoS Negl Trop Dis. 2012;6(10):e1867
pubmed: 23150742
Vaccine. 2019 Oct 3;37 Suppl 1:A85-A87
pubmed: 30342901
Dev Biol (Basel). 2008;131:413-9
pubmed: 18634503
Eur J Immunol. 2000 Jul;30(7):1797-806
pubmed: 10940868
Virus Res. 2011 Mar;156(1-2):121-6
pubmed: 21255623
Nature. 2019 Sep;573(7772):61-68
pubmed: 31435019
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
pubmed: 12184808
Neuroscience. 2020 Jul 15;439:230-240
pubmed: 31376422
Mol Immunol. 2005 Feb;42(2):161-82
pubmed: 15488606
J Neurosci. 2014 Sep 3;34(36):11929-47
pubmed: 25186741
Cancer Res. 2008 Dec 15;68(24):10367-76
pubmed: 19074906
J Invest Dermatol. 2012 Mar;132(3 Pt 1):626-34
pubmed: 22113484
Annu Rev Virol. 2015 Nov;2(1):451-71
pubmed: 26958924
J Virol. 2013 Jul;87(14):8261-5
pubmed: 23698294
J Neurochem. 2005 Jun;93(5):1293-303
pubmed: 15934948
BMC Infect Dis. 2005 Nov 16;5:104
pubmed: 16288653
PLoS Pathog. 2009 Feb;5(2):e1000315
pubmed: 19247444
Neurosci Lett. 2006 Apr 10-17;397(1-2):145-8
pubmed: 16406320
PLoS Pathog. 2016 Dec 15;12(12):e1006041
pubmed: 27977811
Adv Virus Res. 2011;79:165-202
pubmed: 21601048
Crit Rev Microbiol. 2013 Nov;39(4):325-61
pubmed: 22978742
Neuropathology. 2000 Sep;20(3):197-203
pubmed: 11132935
J Virol. 2010 Sep;84(18):9642-8
pubmed: 20592092
PLoS Negl Trop Dis. 2016 Jul 05;10(7):e0004812
pubmed: 27380028
J Neurovirol. 2006 Jun;12(3):229-34
pubmed: 16877304
Front Microbiol. 2016 Nov 07;7:1688
pubmed: 27872612
Front Microbiol. 2018 Mar 20;9:397
pubmed: 29615985
J Neurovirol. 2008 Oct;14(5):368-75
pubmed: 19023689
J Immunol. 2004 Mar 1;172(5):2731-8
pubmed: 14978070
J Vis Exp. 2013 Jan 19;(71):
pubmed: 23380713
J Neurovirol. 2005 Feb;11(1):101-6
pubmed: 15804968
Sci Rep. 2019 Aug 21;9(1):12171
pubmed: 31434934
Trends Immunol. 2017 Mar;38(3):181-193
pubmed: 28161189
Adv Virus Res. 2011;79:91-114
pubmed: 21601044
J Virol. 2012 Sep;86(18):10194-9
pubmed: 22740405
J Neuropathol Exp Neurol. 1989 Nov;48(6):620-30
pubmed: 2477505
J Virol. 2005 Oct;79(19):12554-65
pubmed: 16160183
J Neuroinflammation. 2010 Jan 04;7:1
pubmed: 20047691
J Gen Virol. 1996 Sep;77 ( Pt 9):2137-47
pubmed: 8811013
Patholog Res Int. 2011;2011:374286
pubmed: 21876844
J Immunol. 2006 Apr 1;176(7):4235-43
pubmed: 16547260
Hum Immunol. 2016 Oct;77(10):961-971
pubmed: 27316325
Lancet Neurol. 2013 May;12(5):498-513
pubmed: 23602163
J Leukoc Biol. 2003 Sep;74(3):331-43
pubmed: 12949236
Lab Invest. 1999 Aug;79(8):945-51
pubmed: 10462032
Nucleic Acids Res. 2001 May 1;29(9):e45
pubmed: 11328886
Biomol Ther (Seoul). 2021 Mar 1;29(2):144-153
pubmed: 33262320
J Gen Virol. 1981 Oct;56(Pt 2):372-82
pubmed: 7031182
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2758-63
pubmed: 11226313
Arch Virol. 1977;53(3):269-73
pubmed: 193466
Clin Infect Dis. 2008 Dec 1;47(11):1410-7
pubmed: 18937576
J Med Virol. 2001 Nov;65(3):614-8
pubmed: 11596101
Front Immunol. 2020 Sep 25;11:558341
pubmed: 33072096
Nat Immunol. 2000 Oct;1(4):298-304
pubmed: 11017100
J Proteome Res. 2010 Apr 5;9(4):1795-804
pubmed: 20121167
J Neurosci. 2012 Feb 29;32(9):3154-63
pubmed: 22378888
Virol J. 2004 Sep 23;1:5
pubmed: 15507126
Intervirology. 1974;3(4):256-68
pubmed: 4282379
Lancet Neurol. 2002 Jun;1(2):101-9
pubmed: 12849514
Nat Med. 2013 Apr;19(4):458-64
pubmed: 23455712
J Neurosci. 2006 May 3;26(18):4930-9
pubmed: 16672668
J Virol. 2003 Apr;77(7):4004-14
pubmed: 12634360
Comp Immunol Microbiol Infect Dis. 2011 Dec;34(6):503-12
pubmed: 22005334
Ann N Y Acad Sci. 2009 Feb;1153:256-63
pubmed: 19236348
Elife. 2020 Aug 17;9:
pubmed: 32804078
Adv Virus Res. 2011;79:33-53
pubmed: 21601041
PLoS One. 2008 Apr 30;3(4):e2057
pubmed: 18446239
Sci Rep. 2018 Aug 8;8(1):11858
pubmed: 30089776
Lancet. 2014 Oct 11;384(9951):1389-99
pubmed: 24828901
JAKSTAT. 2013 Oct 1;2(4):e27521
pubmed: 24498542
J Neuroimmunol. 2009 Dec 10;217(1-2):85-9
pubmed: 19857907
Genes Immun. 2006 Mar;7(2):141-9
pubmed: 16421598
J Virol. 2006 Oct;80(20):10270-3
pubmed: 17005706
J Neuroinflammation. 2014 Aug 21;11:146
pubmed: 25182681
J Infect Dis. 2014 Jun 1;209(11):1744-53
pubmed: 24367042
Mol Cell Neurosci. 2008 Sep;39(1):133-41
pubmed: 18619850
PLoS One. 2013 Dec 09;8(12):e81329
pubmed: 24349056
J Gen Virol. 2016 Feb;97(2):316-326
pubmed: 26647356

Auteurs

Lena Feige (L)

Institut Pasteur, Université de Paris, Lyssavirus Epidemiology and Neuropathology Unit, National Reference Center for Rabies, WHO Collaborating Center for Reference and Research on Rabies, Department of Global Health, Paris, France.

Inés Sáenz-de-Santa-María (I)

Institut Pasteur, Université de Paris, Membrane Traffic and Pathogenesis Unit, Paris, France.

Beatrice Regnault (B)

Institut Pasteur, Université de Paris, Genopole, Paris, France.

Rachel Lavenir (R)

Institut Pasteur, Université de Paris, Lyssavirus Epidemiology and Neuropathology Unit, National Reference Center for Rabies, WHO Collaborating Center for Reference and Research on Rabies, Department of Global Health, Paris, France.

Anthony Lepelletier (A)

Institut Pasteur, Université de Paris, Lyssavirus Epidemiology and Neuropathology Unit, National Reference Center for Rabies, WHO Collaborating Center for Reference and Research on Rabies, Department of Global Health, Paris, France.

Ala Halacu (A)

National Agency for Public Health, Chișinău, Moldova.

Randrianasolo Rajerison (R)

University Hospital Center of Befelatanana, Antananarivo, Madagascar.

Sylvie Diop (S)

Infectious Diseases Department, National and University Hospital Center of Fann-Dakar, Dakar, Senegal.

Chhor Nareth (C)

Calmette Hospital, Phnom Penh, Cambodia.

Jean-Marc Reynes (JM)

Virology Unit, Institut Pasteur de Madagascar, Tananarive, Madagascar.

Philippe Buchy (P)

Virology Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia.

Hervé Bourhy (H)

Institut Pasteur, Université de Paris, Lyssavirus Epidemiology and Neuropathology Unit, National Reference Center for Rabies, WHO Collaborating Center for Reference and Research on Rabies, Department of Global Health, Paris, France.

Laurent Dacheux (L)

Institut Pasteur, Université de Paris, Lyssavirus Epidemiology and Neuropathology Unit, National Reference Center for Rabies, WHO Collaborating Center for Reference and Research on Rabies, Department of Global Health, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH